IDIGH symposium and product show

 (IDIGH) has been developed at McGill University to maximize the research effort with a translational focus. We are proud to sponsor their yearly symposium which will be held on Friday, October 19, 2018. In so doing, MédiMabs affirms its continuity in bringing new products on the market and in developing de novo antibodies with research partners in the field of infectious diseases.


Amongst them, we offer a larger variety of reagents to study HIV-1 viral particles () and gp41), to identify infected cells () and assess the cellular pathways harnessed by the virus (,,). In addition to other reagents antibodies against,,we also have antibodies against receptors implied in the pathogen recognition and immune system activation like  and the recently added CCAB-series anti-TLR4

We wish to all the attendees, a great symposium.

Written by
MédiMabs’ Team
Change my preferences

We use cookies to facilitate your navigation and enable certain features. You can see detailed information about all cookies in each consent category below.

Functional cookies (Required)

These cookies are essential for the proper functioning of our website; that’s why you can’t delete them.

Statistical cookies

These cookies allow us to know the use made of our site and its performance, to establish usage statistics and to determine the volumes of attendance and use of the various elements.

Advertising cookies

These cookies are used to provide visitors with personalized advertisements based on previously visited pages and to analyze the effectiveness of the advertising campaign.

Confirm my selection

This site uses cookies, deposited by our website, in order to improve your browsing experience. For more information on the purposes and to customize your preferences by type of cookies used, please visit our privacy policy page.

Accept all
Manage my preferences